Charles River Laboratories expands cell therapy manufacturing facility in Tennessee. | So Good News
[ad_1]
MT Newswires 2022
|
|
|
|
|
|
|
|
|
|
||||
|
||||
Technical Analysis Trends CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
| Short term | Mid-Term | Long term | |
| trend | Rude | Neutral | A wicked one |
Income Statement Evolution
|
sell  Buy it. |
|
| It means consensus | Buy it. |
| Number of analysts | 16 |
| Last closing price | 220,34 $ |
| Average target price | 267,58$ |
| Spread/average target | 21.4% |
[ad_2]
Source link
